HI
INFI

HBK Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

HBK Investments’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-37,611
Closed -$412K – 1158
2015
Q2 		$412K Sell
37,611
-9,089
-19% -$117K ﹤0.01% 764
2015
Q1 		$653K Buy
46,700
+20,300
+77% +$310K 0.01% 678
2014
Q4 		$446K Buy
+26,400
New +$384K 0.01% 759
2013
Q3 		– Sell
-203,000
Closed -$3.3M – 982
2013
Q2 		$3.3M Buy
+203,000
New +$6.28M 0.05% 197

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HBK Investments's INFI Position: Q3 2015 in Review

HBK Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 37,611 shares — an estimated $412K sold.

HBK Investments first reported a position in INFI in Q2 2013 and held it in 4 quarters. The position peaked at $3.3M in Q2 2013. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • HBK Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • HBK Investments sold 37,611 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $412K.
  • HBK Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • HBK Investments's Infinity Pharmaceuticals, Inc. position peaked at $3.3M in Q2 2013.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on HBK Investments's 13F filing for Q3 2015, filed 16 Nov 2015.